• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国排名前 100 的药物和药物类别:受训开方者的更新版“起始处方集”。

The 'top 100' drugs and classes in England: an updated 'starter formulary' for trainee prescribers.

机构信息

Clinical Pharmacology, Institute of Infection and Immunity, St George's, University of London.

St George's University Hospitals NHS Foundation Trust.

出版信息

Br J Clin Pharmacol. 2018 Nov;84(11):2562-2571. doi: 10.1111/bcp.13709. Epub 2018 Aug 10.

DOI:10.1111/bcp.13709
PMID:29975799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6177714/
Abstract

AIMS

Prescribing is a complex skill required of doctors and, increasingly, other healthcare professionals. Use of a personal formulary can help to develop this skill. In 2006-9, we developed a core list of the 100 most commonly prescribed drugs. Our aim in the present study was to update this 'starter formulary' to ensure its continued relevance for prescriber training.

METHODS

We analysed large contemporary primary and secondary care datasets to identify the most frequently prescribed medicinal products. Items were classified into natural groups, broadly following their British National Formulary classification. The resulting drug groups were included in the core list if they comprised ≥0.1% prescriptions in both settings or ≥0.2-0.3% prescriptions in one setting. Drugs from emergency guidelines that did not qualify by prescribing frequency completed the list.

RESULTS

Over 1 billion primary care items and approximately 1.8 million secondary care prescriptions were analysed. The updated list comprises 81 drug groups commonly prescribed in both settings; six from primary care; seven from secondary care; and six from emergency guidelines. Eighty-eight per cent of the formulary was unchanged. Notable changes include entry of newer anti-epileptics and dipeptidyl peptidase-4 inhibitors and exit of phenytoin and thiazolidinediones.

CONCLUSIONS

The relative stability of the core drug list over 9 years and the current update ensure that learning based on this list remains relevant to practice. Trainee prescribers may be encouraged to use this 'starter formulary' to develop a sound basis of prescribing knowledge and skills that they can subsequently apply more widely.

摘要

目的

开处方是医生和越来越多的其他医疗保健专业人员所需的一项复杂技能。使用个人处方集可以帮助培养这种技能。我们在 2006-2009 年开发了一个最常用的 100 种药物的核心清单。本研究的目的是更新这个“起始处方集”,以确保其对处方培训的持续相关性。

方法

我们分析了大型当代初级和二级保健数据集,以确定最常开的药物。项目按其自然组分类,大致遵循英国国家处方集的分类。如果这些药物在两种情况下的处方率都≥0.1%,或者在一种情况下的处方率≥0.2-0.3%,则将其归入核心清单。来自急救指南但不符合处方频率要求的药物则补充到清单中。

结果

分析了超过 10 亿份初级保健项目和大约 180 万份二级保健处方。更新后的清单包括 81 种在两种情况下都常开的药物组;6 种来自初级保健;7 种来自二级保健;6 种来自急救指南。处方集的 88%没有变化。值得注意的变化包括新型抗癫痫药和二肽基肽酶-4 抑制剂的加入,以及苯妥英和噻唑烷二酮类药物的退出。

结论

核心药物清单在 9 年内的相对稳定性和当前的更新确保了基于该清单的学习仍然与实践相关。受训的处方者可能会被鼓励使用这个“起始处方集”来培养他们可以更广泛应用的合理处方知识和技能基础。

相似文献

1
The 'top 100' drugs and classes in England: an updated 'starter formulary' for trainee prescribers.英国排名前 100 的药物和药物类别:受训开方者的更新版“起始处方集”。
Br J Clin Pharmacol. 2018 Nov;84(11):2562-2571. doi: 10.1111/bcp.13709. Epub 2018 Aug 10.
2
Personal Formularies of Primary Care Physicians Across 4 Health Care Systems.4 个医疗体系中初级保健医生的个人处方集。
JAMA Netw Open. 2021 Jul 1;4(7):e2117038. doi: 10.1001/jamanetworkopen.2021.17038.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.电子处方对门诊医疗环境中处方集依从性和通用药物使用的影响:行政索赔数据的回顾性分析
J Manag Care Pharm. 2005 Jun;11(5):410-5. doi: 10.18553/jmcp.2005.11.5.410.
5
Development of a core drug list towards improving prescribing education and reducing errors in the UK.开发核心药物清单以改善英国的处方教育和减少错误。
Br J Clin Pharmacol. 2011 Feb;71(2):190-8. doi: 10.1111/j.1365-2125.2010.03823.x.
6
High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines.斯德哥尔摩对“明智清单”治疗建议的高依从性:对促进合理用药的多方面方法进行的15年回顾性研究
BMJ Open. 2017 May 2;7(4):e014345. doi: 10.1136/bmjopen-2016-014345.
7
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
8
Beginners in prescribing practice: Experiences and perceptions of nurses and doctors.初级处方实践:护士和医生的经验与看法。
J Clin Nurs. 2018 Mar;27(5-6):1103-1112. doi: 10.1111/jocn.14136. Epub 2018 Jan 15.
9
Can rational prescribing be assessed?合理用药可以评估吗?
J R Coll Gen Pract. 1987 Jul;37(300):308-10.
10
Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study.基于世界卫生组织核心药物使用指标对埃塞俄比亚东部部分公立医院合理用药情况的评估:一项横断面研究。
BMC Health Serv Res. 2017 Feb 23;17(1):161. doi: 10.1186/s12913-017-2097-3.

引用本文的文献

1
Evaluation of the Safety of Percutaneous Dilatational Tracheostomies in Patients with Antiplatelet Therapy-A Comparison of Two Single-Step Percutaneous Dilatational Techniques.抗血小板治疗患者经皮扩张气管切开术的安全性评估——两种单步经皮扩张技术的比较
J Clin Med. 2025 Jul 16;14(14):5036. doi: 10.3390/jcm14145036.
2
α-Ketol Rearrangement for Accessing Tetracyclic Natural Products.用于合成四环天然产物的α-酮醇重排反应
Org Lett. 2025 Aug 1;27(30):8154-8157. doi: 10.1021/acs.orglett.5c02235. Epub 2025 Jul 22.
3
Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study.韩国胃酸抑制剂的处方趋势及其与潜在不良事件的关联:一项真实世界横断面研究
Therap Adv Gastroenterol. 2025 Jul 15;18:17562848251356406. doi: 10.1177/17562848251356406. eCollection 2025.
4
MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKS.各国生物样本库中的药物暴露与神经退行性疾病风险
medRxiv. 2025 Jul 7:2025.07.07.25330740. doi: 10.1101/2025.07.07.25330740.
5
Empirically establishing drug exposure records directly from untargeted metabolomics data.直接从非靶向代谢组学数据中凭经验建立药物暴露记录。
bioRxiv. 2024 Oct 26:2024.10.07.617109. doi: 10.1101/2024.10.07.617109.
6
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
7
Association of high LDL concentrations with erectile dysfunction from a Mendelian randomization study.基于孟德尔随机化研究的 LDL 浓度与勃起功能障碍的相关性。
Sci Rep. 2023 Dec 14;13(1):22252. doi: 10.1038/s41598-023-49771-1.
8
Mendelian randomization for cardiovascular diseases: principles and applications.孟德尔随机化在心血管疾病中的应用:原理与方法。
Eur Heart J. 2023 Dec 14;44(47):4913-4924. doi: 10.1093/eurheartj/ehad736.
9
A Reappraisal of the Effects of L-type Ca Channel Blockers on Store-Operated Ca Entry and Heart Failure.L 型钙通道阻滞剂对钙库操纵性钙内流和心力衰竭作用的再评价。
Function (Oxf). 2023 Oct 12;4(6):zqad047. doi: 10.1093/function/zqad047. eCollection 2023.
10
Epidemiology of the idiopathic inflammatory myopathies.特发性炎症性肌病的流行病学
Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6.

本文引用的文献

1
Diagnostic rates and treatment of dementia before and after launch of a national dementia policy: an observational study using English national databases.一项国家痴呆症政策出台前后的痴呆症诊断率及治疗情况:一项使用英国国家数据库的观察性研究
BMJ Open. 2014 Jan 9;4(1):e004119. doi: 10.1136/bmjopen-2013-004119.
2
The established status epilepticus trial 2013.癫痫持续状态试验 2013 版
Epilepsia. 2013 Sep;54 Suppl 6(0 6):89-92. doi: 10.1111/epi.12288.
3
Development of a core drug list towards improving prescribing education and reducing errors in the UK.开发核心药物清单以改善英国的处方教育和减少错误。
Br J Clin Pharmacol. 2011 Feb;71(2):190-8. doi: 10.1111/j.1365-2125.2010.03823.x.
4
Should medical students learn to develop a personal formulary? An international, multicentre, randomised controlled study.医学生是否应该学习制定个人用药处方集?一项国际多中心随机对照研究。
Eur J Clin Pharmacol. 2008 Jun;64(6):641-6. doi: 10.1007/s00228-008-0465-y.
5
Differentiating members of the thiazolidinedione class: a focus on safety.噻唑烷二酮类药物的鉴别:聚焦安全性
Diabetes Metab Res Rev. 2002 Mar-Apr;18 Suppl 2:S23-9. doi: 10.1002/dmrr.252.